Luo Fang

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 5

Top Topics

Cerebrospinal Fluid

Methicillin Resistant Staphylococcus Aureus

Liquid Chromatography Tandem Mass Spectrometry

Newly Diagnosed

Top Venues

Journal of oncology

European journal of clinical pharmacology

Pharmacotherapy

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Like Zhong, Junfeng Zhu, Qi Shu, Gaoqi Xu, Chaoneng He, Luo Fang
A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma. Journal of oncology 2023 (2023)
Gaoqi Xu, Dihong Yang, Chaoneng He, Like Zhong, Junfeng Zhu, Qi Shu, Haiying Ding, Wenxiu Xin, Yinghui Tong, Xiao Zhu, Luo Fang
Population pharmacokinetics and toxicity correlation analysis of free and liposome-encapsulated doxorubicin in Chinese patients with advanced breast cancer. Cancer chemotherapy and pharmacology (2023)
Like Zhong, Junfeng Zhu, Qi Shu, Gaoqi Xu, Chaoneng He, Luo Fang
A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma. Journal of oncology 2023 (2023)
Huijuan Wang, Lingfei Huang, Junyan Wang, Yinghua Ni, Zhengyi Zhu, Peng Gao, Yan Hu, Liwen Zhang, Jufei Yang, Luo Fang
Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies. Pharmacotherapy 40 (12) (2020)
Junyan Wang, Lingfei Huang, Peng Gao, Yan Hu, Yinghua Ni, Zhengyi Zhu, Liwen Zhang, Jufei Yang, Huifen Zhang, Luo Fang
Diltiazem on tacrolimus exposure and dose sparing in Chinese pediatric primary nephrotic syndrome: impact of CYP3A4, CYP3A5, ABCB1, and SLCO1B3 polymorphisms. European journal of clinical pharmacology 77 (1) (2020)
Luo Fang, Yu Song, Xu Weng, Fanzhu Li, Yaping Xu, Nengming Lin
Highly sensitive HPLC-DAD method for the assay of gefitinib in patient plasma and cerebrospinal fluid: application to a blood-brain barrier penetration study. Biomedical chromatography : BMC 29 (12) (2015)